Breaking down extracellular DNA and fibrin, to reduce fluid viscosity and biofilm using intrapleural administration of deoxyribonuclease (DNase) and tPA has recently been demonstrated in a randomized controlled trial to improve outcomes for patients with empyema compared to the use of tPA or DNase alone [29]. The gene discussed is PLAT; the disease is empyema.